• KPNB1-ATF4-BNIP3 Axis Drives Mitophagy in DPSC Differentiati

  2026-05-12

  Zhang et al. uncover a mechanistic link between KPNB1-ATF4-regulated BNIP3-dependent mitophagy and odontoblastic differentiation in dental pulp stem cells (DPSCs). This work advances understanding of mitochondrial quality control in dental tissue regeneration, providing new molecular targets for pulp–dentin complex engineering.

• Targeted Magnetic Stimulation Modulates GABAA ε to Reverse S

  2026-05-12

  This study demonstrates that selective magnetic stimulation of the left prelimbic cortex downregulates the GABAA receptor ε subunit, reversing schizophrenia-like behaviors and synaptic deficits in mouse models. These findings identify Gabre as a promising molecular target for neuromodulation therapies in translational schizophrenia research.

• Pheromone-Driven Neurodevelopment and Degeneration in C. ele

  2026-05-11

  Peng et al. (2023) reveal that early-life pheromone perception in C. elegans fundamentally reshapes neurodevelopment, leading to accelerated neurodegeneration in adulthood. Their findings dissect the molecular and circuit-level mechanisms by which environmental chemical cues influence proteostasis and neuronal longevity, offering a new model for environmentally induced neurodegeneration.

• Chondrocyte-Targeted Nanoparticles Inhibit Ferroptosis in OA

  2026-05-11

  This study pioneers a chondrocyte-targeted nanoparticle system (CS-NAC-NPs) for delivering N-acetylcysteine to osteoarthritic joints, achieving sustained antioxidant activity and pronounced protection against cartilage degeneration. By inhibiting ferroptosis via glutathione maintenance, the approach demonstrates substantial disease-modifying potential for osteoarthritis and exemplifies the translational value of targeted, redox-responsive nanotherapeutics.

• Rotigotine: Dopamine D2/D3 Receptor Agonist in PD Research

  2026-05-10

  Rotigotine enables high-fidelity modeling of dopaminergic signaling, supporting both neuroprotection and motor symptom investigation in Parkinson’s disease research. This guide details validated protocols, advanced use-cases, and actionable troubleshooting for bench scientists seeking reproducible results.

• CDK4/6 and BET Inhibitor Synergy in Pancreatic Cancer Models

  2026-05-09

  Gu et al. (2025) investigated the paradoxical effects of CDK4/6 inhibition in pancreatic ductal adenocarcinoma (PDAC), revealing that combined CDK4/6 and BET inhibition synergistically suppresses tumor growth and reverses epithelial-to-mesenchymal transition (EMT) via modulation of the GSK3β-mediated Wnt/β-catenin pathway. These findings provide a mechanistic rationale for dual-targeted therapeutic strategies in PDAC.

• Dextromethorphan Hydrobromide: Deep Mechanistic Insights for

  2026-05-09

  Explore how Dextromethorphan hydrobromide, a potent NMDA receptor antagonist, advances neuroprotection research through its unique ion channel modulation and evidence-based assay strategies. Discover nuanced insights and protocol parameters not found in standard guides.

• Hoechst 33258: Elevating Tumor pH Modulation and DNA Analysi

  2026-05-08

  This thought-leadership article examines how Hoechst 33258, a bis-benzimide DNA stain from APExBIO, supports cutting-edge research on tumor pH modulation and cell cycle analysis. Integrating mechanistic insight from recent chemo-immunotherapy advances, it delivers strategic guidance for translational researchers optimizing DNA staining workflows in complex, pH-sensitive tumor microenvironments.

• Leucovorin Calcium: Optimizing Methotrexate Rescue in Cancer

  2026-05-07

  Leucovorin Calcium provides robust cell protection and enhances the physiological relevance of advanced gastric cancer assembloid models. Discover practical workflows, troubleshooting strategies, and data-driven protocol parameters to maximize experimental success in antifolate drug resistance and preclinical drug screening.

• Olsalazine Sodium: Workflow Optimization in Inflammation Res

  2026-05-07

  Olsalazine Sodium, a mesalamine dimer, enables sensitive inflammation and cancer research through potent LTB4 chemotaxis inhibition and robust anti-tumor effects. This guide translates recent literature and real-world protocols into actionable steps for maximizing reproducibility and troubleshooting in experimental designs.

• Applied Workflows Using EZ Cap™ Firefly Luciferase mRNA

  2026-05-06

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers robust, reproducible bioluminescence for gene regulation and in vivo imaging. This article translates the latest research and product optimizations into actionable protocols, troubleshooting tips, and application strategies for achieving superior mRNA delivery and signal fidelity.

• Cinoxacin: Precision Profiling and Protocol Optimization in

  2026-05-06

  Explore the scientific foundations and practical nuances of Cinoxacin, a quinolone antibiotic, for advanced urinary tract infection research. This article uniquely bridges molecular pharmacology with protocol decision-making to empower more reproducible, data-driven microbiology studies.

• Synergistic CDK4/6 and BET Inhibition Suppresses Pancreatic

  2026-05-05

  Gu et al. (2025) reveal that combined CDK4/6 and BET inhibition in pancreatic ductal adenocarcinoma (PDAC) achieves superior tumor suppression and reverses EMT by regulating the GSK3β-mediated Wnt/β-catenin pathway. Their rigorous in vitro and in vivo work supports dual targeting as a promising strategy for overcoming the limitations of single-agent therapies in PDAC.

• ML385: Advanced NRF2 Inhibition for Osteoclast and Cancer Re

  2026-05-05

  Explore the unique mechanisms and advanced applications of ML385, a selective NRF2 inhibitor, in modulating oxidative stress and therapeutic resistance. This in-depth guide reveals new insights for cell signaling and bone disease research.

• Prestained Protein Marker (Triple Color): Precision for Adva

  2026-05-04

  Unlock unmatched accuracy in Western blot size verification with the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa). This guide explores how its unique design, including triple-color bands and EDTA-free chemistry, elevates modern phosphoprotein and fluorescent imaging workflows.

15968 records 1/1065 page Next 12345 下5页 Last page